Since skeletal muscle is the major targets of insulin action [27] and the key determinant of the resting metabolic rate [28], thus modulation of the mitochondrial function/efficiency in this tissue has been suggested as a potential approach to treat obesity and insulin resistance [29,30]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.